NovaSure Impedance-Controlled System for Endometrial Ablation

Gallinat, A.; Nugent, W.

doi:10.1016/s1074-3804(05)60405-7

Cited by 70 publications

(41 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…"Incomplete" treatment rates, as assessed by immediate post-operative hysteroscopy, may be reduced with experience. Despite this, the treatment outcomes in terms of amenorrhoea rates and patient satisfaction are comparable to other published inpatient NovaSure™ series, where post-operative hysteroscopy was not employed [8][9][10][11].…”

Section: Discussionsupporting

confidence: 68%

“…NovaSure™ endometrial ablation has been shown to be an effective treatment for women with excessive menstrual bleeding when performed as an inpatient procedure under general anaesthesia [8][9][10][11]. The current study is the first to show that NovaSure™ endometrial ablation is feasible, safe and effective for the treatment of HMB in the outpatient setting using local anaesthesia.…”

Section: Discussionmentioning

confidence: 62%

“…The current study is the first to show that NovaSure™ endometrial ablation is feasible, safe and effective for the treatment of HMB in the outpatient setting using local anaesthesia. Moreover, this study demonstrates that the effectiveness of outpatient treatment, in terms of amenorrhoea rates, reduction in menstrual bleeding, patient satisfaction and improvements in HRQL, are the same as procedures performed in the more traditional inpatient or day-case setting under general anaesthesia, both in the control group of this study and when compared to other published inpatient studies [8][9][10][11]. In contrast to other studies, we also chose to present clinically relevant combined "amenorrhoea and spotting rates."…”

Section: Discussionmentioning

confidence: 92%

“…The NovaSure™ endometrial ablation system and the recommended surgical technique have been previously described [11,12]. Those women undergoing outpatient endometrial ablation were advised not to fast pre-operatively and had a standard local anaesthetic protocol, as previously described [13].…”

Section: Study Design and Populationmentioning

confidence: 99%

See 3 more Smart Citations

Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system

2008

View full text Add to dashboard Cite

The objective of this paper was to assess the feasibility and efficacy of the NovaSure™ endometrial ablation system in the outpatient setting using local anaesthesia and to compare this with the standard day-case procedure under general anaesthesia. A prospective cohortcontrolled study was undertaken at a university teaching hospital. The patient cohort was made up of 38 women with heavy menstrual bleeding refractory to medical therapy where endometrial ablation was indicated. Endometrial ablation using the NovaSure™ impedance-controlled ablative system was undertaken to compare outpatient treatment using local cervical anaesthetic (experimental group, n=18) with inpatient treatment under general anaesthesia (control group, n=20). The subjective self-assessment of uterine bleeding symptoms, patient satisfaction and health-related quality of life (HRQL; multi-attribute utility assessment) measures at six months following treatment were noted. Participants were also asked as to whether they would subsequently recommend the treatment, based on their experience. All procedures were successfully accomplished. Completed outcome questionnaires were returned by 17/18 (94%) women treated as outpatients and by 13/20 (65%) as inpatients. Overall, 27/30 (90%) women reported an improvement in menstrual bleeding symptoms, with an amenorrhoea rate of 37% (95% CI 20-56%) and a combined amenorrhoea/spotting rate of 53% (95% CI 34-72%). There was no significant difference between the outpatient and inpatient treatment groups in terms of improvement in menstrual blood loss (94% vs. 84%, P=0.6), amenorrhoea (29% vs. 46%, P=0.5), amenorrhoea/ spotting (47% vs. 62%, P=0.5), satisfaction (82% vs. 85%, P=1.0), improvement in HRQL (P=0.3) and treatment setting recommendation (88% vs. 77%, P=0.7). From our results, we conclude that NovaSure™ impedance-controlled endometrial ablation is an effective, safe and feasible treatment for heavy menstrual bleeding in both the outpatient and traditional inpatient settings. A choice of treatment settings should be offered to women suitable for this procedure.

show abstract

Section: Discussionsupporting

confidence: 68%

Section: Discussionmentioning

confidence: 62%

Section: Discussionmentioning

confidence: 92%

Section: Study Design and Populationmentioning

confidence: 99%

See 2 more Smart Citations

Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system

2008

View full text Add to dashboard Cite

show abstract

“…The NEA device has exceptionally high acceptability of use by gynaecologists (> 98%) [5]. NEA is an effective form of endometrial ablation, with success rates in terms of amenorrhea ranging from 30-75%, depending on length of follow up [6] and very few patients experience menorrhagia at 12 months (3.9%) [7]. Some debate still exists about the best management for women with dysmenorrhea and HMB, especially for those with large uterine cavities.…”

Section: Resultsmentioning

confidence: 99%

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Gad¹,

Rigby²,

Vemuri³

et al. 2017

Obstet Gynecol Cases Rev

View full text Add to dashboard Cite

Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation

Xie

Wan

et al. 2021

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Objective: To evaluate the efficiency, postoperative hysterectomy rate, and influencing factors for therapeutic effect of the NovaSure endometrial ablation procedure in abnormal uterine bleeding (AUB). Methods:We conducted a retrospective cohort study of 2152 patients from the Department of Gynecology at the Third Xiangya Hospital, CSU from October 2010 to December 2018. Results:From the first year to the eighth year after operation, annual effective rate was above 95.24%, and the differences were not statistically significant. There are statistically significant differences between the effective and ineffective groups with regard to age, intrauterine polyps, total length of the uterus, systemic coagulation disorder, and preoperative hemoglobin. A multivariate logistic regression analysis showed that the risk factors associated with systemic coagulation disorders (P = 0.027) and high total uterine length (P = 0.003) affected NovaSure efficacy in the treatment of AUB. By December 2019, the postoperative hysterectomy rate was 1.86% (40/2152) and the complication rate was 1.67% (36/2152). Conclusion:NovaSure is a reliable treatment for AUB and serious medical complications because of its simple operation, low amount of bleeding, quick postoperative recovery, and safe and effective short-term and long-term efficacy. However, it should be carefully selected for patients with a total uterus length exceeding 10 cm.

show abstract

NovaSure Impedance-Controlled System for Endometrial Ablation

Cited by 70 publications

References 18 publications

Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system

Outpatient versus day-case endometrial ablation using the NovaSure™ impedance-controlled ablative system

Outcome of Novasure Endometrial Ablation in Women with Heavy Menstrual Bleeding with or without Dysmenorrhoea, Including Those with Uterine Cavity Length More Than 6.5 cm

Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation

Contact Info

Product

Resources

About